[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/DOID_8469",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/DOID_8469"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/drugbank:DB00558"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "relenza an influenza virus neuraminidase inhibitor nai is indicated for treatment of acute uncomplicated influenza type a and b infections 1 1 prophylaxis of influenza 1 2 important limitations of use not recommended for treatment or prophylaxis of influenza in 5 1 not proven effective for 1 3 1 3 not a substitute for annual influenza vaccination 1 3 consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use relenza 1 3 relenza zanamivir inhalation powder is indicated for treatment of uncomplicated acute illness due to influenza a and b virus in adults and pediatric patients aged 7 years and older who have been symptomatic for no more than 2 days relenza is indicated for prophylaxis of influenza in adults and pediatric patients aged 5 years and older see warnings and precautions 5 1"
    } ],
    "https://w3id.org/biolink/vocab/association_type" : [ {
      "@id" : "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation"
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://schema.org/TreatmentIndication"
    } ]
  }, {
    "@id" : "https://identifiers.org/drugbank:DB00558",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-06-15T18:36:10.185+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "D8JBLUi/KjWeRBuIhOSHbhHP0zPDwmbvDFmkkpI1VByhDSYuDzixpk7qGFqntr/GaboGlDAexBWZYnnUUWwuAUTrmVuXP4cJlP311DyPjLLQAeCiXEqbyPLhPns4xstJjmjTph9MlvYUtPlw2a1ksmjfyRomwdTVJq+QTrgmOZc="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0#pubinfo"
} ]